Skip to content
★ Sign in to follow
JM
Total declarations
27
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (17 ops.)
€2.0M

Latest filing published 12 Sept 2018 for bluebird bio, Inc., €56k.

Filing timeline

BuySale
James Mandell

Insider track record

Disclosed buys
0
Disclosed sells
17
Signal history

James Mandell: trading record in brief

This profile gathers the share dealings of James Mandell in bluebird bio, Inc. In total, 27 filings cover trades dated from 10 August 2015 to 10 September 2018.

No open-market purchase appears, only 17 sales worth €2.0M. Besides market trades, the filings include 3 share grants and 7 option exercises. In 2018 alone, the filings show no purchases and 3 sales.

The record was last updated on 12 September 2018 with an open-market sale (€56k) in bluebird bio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to James Mandell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations27 total

25 of 27 declarations